CoChat

Liraglutide Attenuates Myocardial Fibrosis via Inhibition of AT1R-Mediated ROS Production in Hypertensive Mice

Chen, Peng, Yang, Fen, Wang, Wenya, Li, Xiao, Liu, Dongling, Zhang, Yongxi, Yin, Guotian, Lv, Fenghua, Guo, Zhikun, Mehta, Jawahar L., Wang, Xianwei · 2021 · Journal of Cardiovascular Pharmacology and Therapeutics

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

Background/Aims: Glucagon-like peptide-1 receptor agonist liraglutide has been reported to exert cardioprotective effects, but its effect on cardiac fibrosis remains controversial. The aim of this study was to investigate the effects of liraglutide on cardiac fibrosis and potential mechanisms. Methods: C57BL/6 mice (3-month old) were randomly divided into control, hypertension, and hypertension + liraglutide groups. The hypertensive state was created by infusion of Ang II (100 ng/kg·min) for 4 weeks through subcutaneously implanted osmotic pumps. The control mice were infused with saline. Mice were also given vehicle or liraglutide (400 μg/kg·day). Blood pressure (BP), blood sugar, myocardial fibrosis, AT1R expression, and reactive oxygen species (ROS) levels were measured. To further elucidate the mechanisms of fibrosis, mouse cardiac fibroblasts were isolated and treated with liraglutide (300 nM/L) or losartan (10 μM) for 3 hours, followed by Ang II (10 −7 M) for additional 12 hours. Reactive oxygen species production and expressions of collagen-1 and -3 were measured. Results: Liraglutide reduced BP and blood sugar but did not affect the body weight of the hypertensive mice. Liraglutide also inhibited collagen accumulation, AT1R expression, and ROS generation in the hearts of the hypertensive mice. In in vitro studies, pretreatment with liraglutide and losartan (as control) markedly inhibited Ang II-induced ROS production and collagen expression in the cultured cardiac fibroblasts. Conclusion: Liraglutide reduces myocardial fibrosis in the hypertensive mice, which appears to be dependent on at least in part inhibition of ROS production.

Overview

Integrity signals

Registry

Crossref · 10.1177/1074248420942007

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 47 references

Research works printed but not linked: 2

  1. Huang DD, 2018, Eur Rev Med Pharmacol Sci, 22, 4648
  2. Li R, 2019, Front Pharmacol, 10, 10537

Cited by

See all 31

Metadata

Authors
Chen, P., Yang, F., Wang, W., Li, X., Liu, D., Zhang, Y., Yin, G., Lv, F., Guo, Z., Mehta, J. L., & Wang, X.
Affiliations
  • Zhengzhou University (CN)
  • Henan Medical University (CN)
  • First Affiliated Hospital of Xinxiang Medical University (CN)
  • Central Arkansas Veterans Healthcare System (US)
Corresponding author
  • Mehta, Jawahar L.
  • Wang, Xianwei
Venue
Journal of Cardiovascular Pharmacology and Therapeutics
Published
2020-07-20
Volume
26
Issue
2
Pages
179-188
ISSN
  • 1074-2484 (ISSN-L)
  • 1940-4034
OpenAlex
W3044882533
Cited by
31
References
47
Citations by year
2026: 4 · 2025: 3 · 2024: 4 · 2023: 5 · 2022: 10 · 2021: 5
FWCI
3.09
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Cardiovascular Pharmacology and Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (U1804166 and 81873459)
  • henan university (19HASTIT004)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Keywords
liraglutide, myocardial fibrosis, angiotensin II, angiotensin II type 1 receptor, reactive oxygen species, hypertension, GLP-1 receptor agonists, cardiac fibroblasts, collagen expression, losartan, cardioprotection
MeSH terms
Liraglutide, Animals, Fibrosis, Heart, Hypertension, Male, Mice, Inbred C57BL, Myocardium, Reactive Oxygen Species, Receptor, Angiotensin, Type 1, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Liraglutide Attenuates Myocardial Fibrosis via Inhibition of AT1R-Mediated ROS Production in Hypertensive Mice. https://app.cochat.ai/papers/10.1177/1074248420942007
The paper
Chen, P., Yang, F., Wang, W., Li, X., Liu, D., Zhang, Y., Yin, G., Lv, F., Guo, Z., Mehta, J. L., & Wang, X. (2021). Liraglutide Attenuates Myocardial Fibrosis via Inhibition of AT1R-Mediated ROS Production in Hypertensive Mice. Journal of Cardiovascular Pharmacology and Therapeutics. https://doi.org/10.1177/1074248420942007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.